Ghent University Academic Bibliography

Your filters: cql: parent exact "HAEMATOLOGICA-THE HEMATOLOGY JOURNAL"

Add to list
- Journal Article
- A1
- open access
RHAMM/HMMR (CD168) is not an ideal target antigen for immunotherapy of acute myeloid leukemia

SYLVIA SNAUWAERT (UGent) , Stijn Vanhee (UGent) , Glenn Goetgeluk (UGent) , Greet Verstichel (UGent) , Yasmine Van Caeneghem, Imke Velghe (UGent) , Jan Philippé (UGent) , Zwi N Berneman, Jean Plum (UGent) , Tom Taghon (UGent) , et al.

(2012) HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. 97(10). p.1539-1547
Add to list
- Journal Article
- A1
- open access
T-lymphoid differentiation potential measured in vitro is higher in CD34+CD38-/lo hematopoietic stem cells from umbilical cord blood than from bone marrow and is an intrinsic property of the cells

Magda De Smedt (UGent) , Georges Leclercq (UGent) , Bart Vandekerckhove (UGent) , Tessa Kerre (UGent) , Tom Taghon (UGent) and Jean Plum (UGent)

(2011) HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. 96(5). p.646-654
Add to list
- Journal Article
- A1
Residues Arg568 and Phe592 contribute to an antigenic surface for anti-ADAMTS13 antibodies in the spacer domain

Wouter Pos, Nicoletta Sorvillo, Rob Fijnheer, Hendrik Feys (UGent) , Paul HP Kaijen, Gestur Vidarsson and Jan Voorberg

(2011) HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. 96(11). p.1670-1677
Add to list
- Conference Paper
- C3
Anti-CD22 immunoconjugate inotuzumab ozogamicin (CMC-544) + rituximab: clinical activity in patients with relapsed/refractory follicular or 'aggressive' lymphoma

G Verhoef, N Dang, M Smith, Fritz Offner (UGent) , P Johnson, A Rohatiner, J Kaufman, E Gine, B Coiffier, M Czuczman, et al.

(2010) HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. 95(suppl. 2). p.238-238
Add to list
- Conference Paper
- C3
Presentation and outcome of children with down syndrome and acute lymphoblastic leukemia in the eortc children's leukemia group protocol 58951

Veerle Mondelaers (UGent) , Barbara De Moerloose (UGent) , S Suciu, A Ferster, P Lutz, A Uyttebroeck, D Plantaz, L Norton, N Sirvent, A Robert, et al.

(2010) HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. 95(Suppl. 2). p.260-260
Add to list
- Conference Paper
- C3
Rituximab maintenance for 2-years significantly improves the outcome of patients with untreated high tumor burden follicular lymphoma after response to immunochemotherapy: results of the PRIMA study

G Salles, J Catalano, P Feugier, Fritz Offner (UGent) , R Bouabdallah, D Caballero, P Brice, LM Pedersen, C Haioun, D Belada, et al.

(2010) HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. 95(suppl. 2). p.229-229
Add to list
Rho GTPase Cdc42 is essential for human T-cell development

Kaatje Smits, Veronica Iannucci (UGent) , Veronique Stove (UGent) , Peter Van Hauwe, Evelien Naessens (UGent) , Pieter Meuwissen (UGent) , Kevin Ariën (UGent) , Mostafa Bentahir (UGent) , Jean Plum (UGent) and Bruno Verhasselt (UGent)

(2010) HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. 95(3). p.367-375
Add to list
- Conference Paper
- C3
Asparaginase levels, antibodies and silent inactivation in childhood acute lymphoblastic leukemia

Veerle Mondelaers (UGent) , M Dewulf, Brigitte Wuyts (UGent) , Brecht De Cuyper, Yves Benoit and Barbara De Moerloose (UGent)

(2010) HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. 95(Suppl. 2). p.257-257
Add to list
- Conference Paper
- C3
Microrna expression in pediatric precursor-B acute lymphoblastic leukemia: biology, classification and prognosis

Tim Lammens (UGent) , Barbara De Moerloose (UGent) , Jonas Van Baelen (UGent) , Joni Van der Meulen (UGent) , Pieter Mestdagh (UGent) , Bruno Verhasselt (UGent) , Jan Philippé (UGent) , Franki Speleman (UGent) and Yves Benoit

(2010) HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. 95(Suppl. 2). p.255-255
Add to list
- Conference Paper
- C3
Is the risk of developing AML or MDS increased in X-linked neutropenia

K Beel, M Cotter, J Blatny, C Chatelain, A Uyttebroeck, Barbara De Moerloose (UGent) , Nadine Van Roy (UGent) , G. Verhoef, H Demuynck and P Vandenberghe

(2009) HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. p.244-245

Academic Bibliography

RHAMM/HMMR (CD168) is not an ideal target antigen for immunotherapy of acute myeloid leukemia

T-lymphoid differentiation potential measured in vitro is higher in CD34+CD38-/lo hematopoietic stem cells from umbilical cord blood than from bone marrow and is an intrinsic property of the cells

Residues Arg568 and Phe592 contribute to an antigenic surface for anti-ADAMTS13 antibodies in the spacer domain

Anti-CD22 immunoconjugate inotuzumab ozogamicin (CMC-544) + rituximab: clinical activity in patients with relapsed/refractory follicular or 'aggressive' lymphoma

Presentation and outcome of children with down syndrome and acute lymphoblastic leukemia in the eortc children's leukemia group protocol 58951

Rituximab maintenance for 2-years significantly improves the outcome of patients with untreated high tumor burden follicular lymphoma after response to immunochemotherapy: results of the PRIMA study

Rho GTPase Cdc42 is essential for human T-cell development

Asparaginase levels, antibodies and silent inactivation in childhood acute lymphoblastic leukemia

Microrna expression in pediatric precursor-B acute lymphoblastic leukemia: biology, classification and prognosis

Is the risk of developing AML or MDS increased in X-linked neutropenia

Contents

Support

Contact